II 118th CONGRESS 1st Session S. 1120 IN THE SENATE OF THE UNITED STATES March 30, 2023 Ms. Hassan (for herself and Mr. Braun ) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions A BILL To improve the actions available to eligible product developers in the event of delays in receiving covered product for purposes of generic drug or biosimilar biological product development.